Home › Sources Policy
Evidence-first research

Sources Policy

Our sources policy: which sources we prefer, what we avoid, how we handle conflicting evidence and why citations sit close to claims.

Evidence ReviewedUpdated November 13, 2026Sources CitedAffiliate Transparent
§
Sources Policy

Good conclusions depend on good sources. This policy explains how we choose and cite them.

Preferred Sources

  • Cochrane and other systematic reviews
  • Peer-reviewed trials indexed in PubMed
  • Clinical guidelines and government health agencies (NIH, NIAMS, NCCIH, FDA)
  • The seller’s own label and terms, for product facts

What We Avoid

  • Press-release advertorials
  • Unverified ratings and testimonials
  • Look-alike “official” sites
  • News articles used as clinical evidence

Conflicting Sources

When sources disagree, we favor the higher-quality and more recent evidence and say plainly that uncertainty exists.

Citation Proximity

We place citations on the same page as the claim they support, so readers can check them without hunting.

Sources & References

We prioritize primary product information, regulatory sources, peer-reviewed research and recognized clinical guidance. Seller claims are not treated as independent clinical evidence.

  1. Cochrane review: Pine bark (Pinus spp.) extract for treating chronic disorders, 2020
  2. U.S. FDA: Dietary supplements
  3. NIH Office of Dietary Supplements: What you need to know

Related Research

Editorial owner: JointVive Reviews Editorial Team · Last reviewed: November 13, 2026

Current JointVive Offer

Ready to Check JointVive?

Visit the current JointVive seller website to review the latest package pricing, shipping and guarantee terms before ordering.

Affiliate disclosure: we may earn a commission if you purchase through this link, at no additional cost to you.